OrganiGram (NASDAQ:OGI) posted its quarterly earnings results on Monday. The company reported ($0.07) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.02 by ($0.09), Briefing.com reports. The business had revenue of $30.36 million for the quarter, compared to the consensus estimate of $30.81 million. The company’s quarterly revenue was up 782.6% on a year-over-year basis.
OGI opened at $6.85 on Thursday. OrganiGram has a twelve month low of $2.97 and a twelve month high of $8.44.
OGI has been the topic of a number of recent analyst reports. Jefferies Financial Group increased their price target on shares of Monster Beverage from $65.00 to $70.00 and gave the stock a “buy” rating in a research note on Friday, May 3rd. Paradigm Capital initiated coverage on shares of OrganiGram in a research note on Wednesday, April 17th. They set a “buy” rating on the stock. Finally, Pi Financial set a $12.00 price target on shares of OrganiGram and gave the stock a “buy” rating in a research note on Monday.
OrganiGram Holdings Inc, through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders.
Recommended Story: Investing strategies using the yield curve
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.